SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Annual Wellness Visit, Subsequent — Satchel Paige

PatientSatchel Paige
Date of birth1953-07-07
IdentifiersMRN HR-ML047-SYN; SSN (made up) 000-47-3381
Document date2026-10-06
AuthorDelphine Whitaker-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Subsequent annual wellness visit, two weeks after an exacerbation. [S]

History of Present Illness

Mr. Paige, 73, comes for his subsequent annual wellness visit two weeks after a moderate COPD exacerbation; his last wellness visit was a year ago at his previous clinic. He finished the prednisone and doxycycline ten days ago and is back to his usual breathing, uses albuterol about once a day, and returned to pulmonary rehabilitation last week. He takes his umeclidinium-vilanterol every morning and atorvastatin every evening without muscle aches. He completed the health risk assessment beforehand. He wants all his vaccines today so that, in his words, the next cold does not knock him down. [S]

ElementDetail
VisitSubsequent annual wellness visit, age 73
Active conditionsCOPD, GOLD 2, group B, recovered from a moderate exacerbation; hyperlipidemia on atorvastatin; former smoker
MedicinesUmeclidinium-vilanterol daily; albuterol as needed; atorvastatin 20 mg
Mood and cognitionPHQ-2 0; Mini-Cog 5

Health risk assessment. Completed by the patient on paper in the waiting room and reviewed with him by Dr. Whitaker-Osei. [S]

DomainFinding
Self-rated healthFair to good; better since rehabilitation
PsychosocialLives with his wife; a large family nearby; active in his church; speaks at schools
AlcoholA beer on a holiday; AUDIT-C 1 at intake
TobaccoFormer smoker, about 30 pack-years, stopped eleven years ago; no secondhand smoke at home
Physical activityPulmonary rehabilitation twice a week and walks on other days
NutritionRegular meals; weight steady
SleepSeven hours on two pillows by habit; no snoring reported
Safety at homeSmoke and carbon monoxide alarms; no firearms at home; gas stove used with the window open
FallsNo falls
Activities of daily livingIndependent
Hearing and visionReading glasses; hearing good
Oral healthDentures; dental visit this year
Cost and accessThe maintenance inhaler is covered through his drug plan with a low copayment; rides to rehabilitation from a church volunteer

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever, weight loss or night sweats
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeCold resolved
RespiratoryPositiveUsual breathlessness after a block; a little clear morning sputum; no wheeze
CardiovascularNegativeNo chest pain, palpitations or ankle swelling
GastrointestinalNegativeNo indigestion or change in bowel habit
GenitourinaryNegativeNo hesitancy or poor stream on the inhaler
MusculoskeletalNegativeNo muscle aches on atorvastatin; old shoulder and arm stiffness only
IntegumentaryNegativeNo rashes
NeurologicalNegativeNo numbness, weakness or memory trouble
PsychiatricNegativeMood good; PHQ-2 0

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 micrograms per inhalation metered-dose inhaler with a spacer, two inhalations every four hours as needed for breathlessnessTwo inhalations with a spacer every 4 hours as neededRespiratory tract route2026-07-14activeS
Umeclidinium 62.5 micrograms with vilanterol 25 micrograms dry powder inhaler (a LAMA with a LABA), one inhalation once a dayOne inhalation each morning; a strong, deep breath inRespiratory tract route2026-07-28activeS
Atorvastatin 20 mg tablet once a dayOne tablet each eveningOral route2026-07-14activeS
Prednisone 40 mg (two 20 mg tablets) by mouth each morning for five daysTwo tablets each morning with food for five daysOral route2026-09-22 to 2026-09-26completedS
Doxycycline 100 mg capsule by mouth twice a day for five daysOne capsule twice a day with a full glass of water, sitting up, for five daysOral route2026-09-22 to 2026-09-26completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-06Body height191cmS
2026-10-06Body weight83kgS
2026-10-06Body mass index (BMI) [Ratio]22.8kg/m2S
2026-10-06Systolic blood pressure128mm[Hg]S
2026-10-06Diastolic blood pressure76mm[Hg]S
2026-10-06Heart rate76/minS
2026-10-06Respiratory rate16/minS
2026-10-06Body temperature36.6CelS
2026-10-06Oxygen saturation in Arterial blood by Pulse oximetry95%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-06Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-06Total score [Mini-Cog]5{score}S

Physical Exam

Vital signs recorded on 2026-10-06; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 83.0 kg, BMI 22.8; blood pressure 128/76; pulse 76; oxygen saturation 95 percent on room air
Ears, nose, mouth, and throatThroat normal; dentures fit well
NeckNo nodes; no raised jugular venous pressure
RespiratoryReduced breath sounds at the bases; no wheeze or crackles
CardiovascularRegular rhythm; no murmur; no edema
AbdomenSoft; no pulsatile mass
MusculoskeletalTimed Up and Go 9 seconds

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness on exertion for about two years, now after one flight of stairs or a block on the level (mMRC 2), with a morning cough and a little clear sputum most days; no chest pain, ankle swelling, orthopnea, wheeze at rest or weight loss; a former smoker of about 30 pack-years; cause under evaluation with spirometry and a pulmonology consultationresolvedconfirmed R06.09S — Synthetic presenting problem anchored to his documented emphysema; superseded when spirometry at the consultation confirmed COPD.
Chronic obstructive pulmonary disease, GOLD grade 2 (post-bronchodilator FEV1/FVC 0.58, FEV1 61% predicted by the race-neutral GLI Global equations), GOLD group B (CAT 18, mMRC 2, no exacerbation in the past year); alpha-1 antitrypsin normal; blood eosinophils 0.08 x 10^3/uL; synthetic modern diagnosis linked to his documented emphysemaactiveconfirmed J44.9S — Synthetic modern diagnosis made at the consultation, anchored to his documented emphysema; its onset and course in the modern episode are synthetic.
Former cigarette smoker, about 30 pack-years, stopped eleven years ago on his own; no use sinceactiveconfirmed Z87.891S — Synthetic smoking history: whether he smoked is not documented in the sources read, so the history is synthetic and labeled as such.
Hyperlipidemia: LDL 148 mg/dL, HDL 44 and triglycerides 160 at intake; estimated 10-year cardiovascular risk about 18 percent; atorvastatin started by shared decisionactiveconfirmed E78.5S — Synthetic cardiovascular risk factor anchored to his documented heart trouble; not a claim about his real lipids.
Moderate exacerbation of COPD with a viral cold: more breathlessness, more sputum turning green, and wheeze for three days; oxygen saturation 92 percent; no pneumonia on chest X-ray; treated at home with prednisone and doxycycline; recoveredresolvedconfirmed J44.1S — Synthetic exacerbation at the sick visit; not a historical claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today128/76 mmHg
Lipid managementUp to dateLDL 86 mg/dL on atorvastatin 20 mg four weeks ago
Diabetes screeningUp to dateHbA1c 5.6% at intake
Colorectal cancer screeningUp to dateColonoscopy five years ago without polyps, reported by his previous clinic; further screening after 75 by shared decision
Lung cancer screeningUp to dateLow-dose CT nine weeks ago, Lung-RADS 2; next in one year
Abdominal aortic aneurysm screeningOrderedOne-time ultrasound for men 65 to 75 who have ever smoked
Prostate cancer screeningNot indicatedPSA screening is not recommended at 70 and older
Hepatitis C screeningOrderedOnce for adults; drawn today
Hepatitis B screeningOrderedTriple panel once for all adults; drawn today
Osteoporosis screeningNot indicatedEvidence insufficient for screening men; one five-day steroid course does not change this; revisit if steroid courses recur
Depression screeningCompleted todayPHQ-2 0
Cognitive assessmentCompleted todayMini-Cog 5, normal
Unhealthy alcohol useUp to dateAUDIT-C 1 at intake
Tobacco useCompleted todayFormer smoker; remains smoke-free
Falls riskCompleted todayNo falls; Timed Up and Go 9 seconds
Influenza vaccineCompleted todayHigh-dose vaccine today
RSV vaccineCompleted todaySingle dose today, for an adult 50 to 74 with chronic lung disease
COVID-19 vaccineCompleted todayThis season's vaccine today after discussion
Zoster vaccineCompleted todayFirst recombinant dose today; second in two to six months
Pneumococcal vaccineUp to datePCV20 at intake; no further dose needed
Tetanus, diphtheria, and pertussisUp to dateTdap at intake

Immunizations given today: Influenza vaccine, high-dose, this season; Respiratory syncytial virus vaccine, single dose; COVID-19 mRNA vaccine, this season's formula; Recombinant zoster vaccine, dose 1 of 2 [S]

Guideline basis: Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025); Lung Cancer: Screening (2021); Adult Immunization Schedule by Age (2026); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Abdominal Aortic Aneurysm: Screening (2019); Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 (2023)

Follow-up: Fifteen-week review in three weeks. Aortic ultrasound and hepatitis results by then. Second zoster dose in two to six months. Next wellness visit in one year. Next scheduled visit 2026-10-27: fifteen-week review after an exacerbation and pulmonary rehabilitation: symptoms, exacerbation history, GOLD group, oxygen, the action plan and the plan ahead. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 25 minutes, with his consent. He named a health care agent and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying at home in Kansas City, being with the people he loves, and still being able to talk with young players. If his lungs failed in a flare that could recover, he would accept a short trial of a breathing machine in intensive care, but not long-term life support if there were little chance of returning home. He will review these wishes with his family, and the plan will be revisited yearly or after any hospital stay. [S]